PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pulmonary Division, Lady Davis Carmel Medical Center, Faculty of Medicine Technion Institute of Technology, Haifa, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. Electronic address: adir-sh@zahav.net.il.\', \'Université Paris-Saclay, Le Kremlin-Bicêtre, France; Department of Respiratory and Intensive Care Medicine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bicêtre, Le Kremlin-Bicêtre, France; INSERM, UMR_S 999, Hôpital Marie Lannelongue, Le Plessis-Robinson, France.\', \'Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Department of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0091-6749(21)00938-610.1016/j.jaci.2021.06.006
?:hasPublicationType
?:journal
  • The Journal of allergy and clinical immunology
is ?:pmid of
?:pmid
?:pmid
  • 34144110
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all